The frequency of GLUT1 positivity was particularly high in squamous cell carcinomas of various sites of origin (92.9%-100%), urothelial neoplasms (91.3%-98.7%), and carcinomas of the ovary and the endometrium (up to 100%). This evidence concerns the gene SLC2A1 and urothelial neoplasm.